1Maisels MJ. Screening and early postnatal management strate- gies to prevent hazardous hyperbilirubinemia in newborns of 35 or more weeks of gestation [ J ]. Semin Fetal Neonatal Med, 2010, 15: 129-135.
3Maisels M J, Kring E. Length of stay, jaundice, and hospi- tal readmission [J]. Pediatrics, 1998, 101: 995-998.
4Burgos AE, Schmitt SK, Stevenson DK, et al. Readmission for neonatal jaundice in California, 1991-2000: trends and implications [J]. Pediatrics, 2008, 121: e864-e869.
5De Luca D, Carnielli VP, Paolillo P. Neonatal hyperbilirubi- nemia and early discharge from maternity ward [ J ]. Eur J Pediatr, 2009, 68: 1025-1030.
6Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent sig- nificant hyperbilirubinemia in healthy term and near-term newborns [J]. Pediatrics, 1999, 103: 6-14.
7Skae MS, Moise J, Clarke P. ls current management of neonatal jaundice evidence based? [ J]. Arch Dis Child Fetal Neonatal Ed, 2005, 90: F540.
8Najati N, Gharebaghi MM, Mortazavi F. Underlying etiolo- gies of prolonged icterus in neonates [ J ]. Pak J Biol Sci, 2010, 13: 711-714.
